Moderate alcohol consumption is associatedw ith lowerl evels of several coagulation factors. It is an establishedprotectivefactor forc ardiovascular disease;however,the effect on venous thrombosis is unknown. In al arge population-basedc ase-control study,wee valuatedt he associationb etween alcohol consumption and theriskofv enous thrombosis.TheMEGAstudy includedconsecutivepatientswith afirstvenous thrombosis between March1 999 and September2 004 from sixa nticoagulationclinics in the Netherlands.Partnersofpatientswereasked to participate,and additional controls were recruitedu sing a random digitdialling method.All participantscompleted astandardizedq uestionnaire,a nd blood samplesw erec ollected. A total of 4,423 patients and 5,235 controls were included in the analyses.Alcoholc onsumption was associated with ar educed risk of venous thrombosis,with 2-4 glassesper dayresulting in Compared to abstainers,fibrinogen levels were decreasedi ni ndividualsw ho consumed alcohol (maximumd ecrease:0.30 g/l). FactorVIIand vonWillebrand levels were mildly decreasedinthese individuals but not consistentlyoverthe categorieso fa lcoholc onsumption. In conclusion, alcohol consumption is associated with areduced risk of venous thrombosis, which maybeinpartmediated by decreasedfibrinogen levels.
Introduction
The protective effect of moderate and the harmful effect of heavy alcoholc onsumption on the risk of arterial disease has been shown in manyepidemiologicalstudies (1) . Similar effects of alcohol consumption on the risk of venous thrombosis arealso not unlikelyc onsidering the effect of alcohol consumption on coagulation factors. As ystematic reviewr eported an association between moderate alcoholi ntakea nd reducedl evelso ff ibrinogen, factor VII and vonWillebrand factor,whereasheavy and bingea lcohold rinking wasa ssociatedw ith increased levels of fibrinogen and factor VII (2) .
Fewstudieshavereported on the relationship between alcoholc onsumption and venous thrombosis.I na nI talianc ohort study of elderlyindividuals, lowtomoderate alcohol consumption appeared beneficial with relativer isks of 0.7 for less than one drink amonth, 0.6 for less than one ounce per dayand 0.5 for one or more than one ounce per day (3) . In contrast, twoUScohortstudiesfound no effect of alcohol consumption on the risk of venous thrombosis (4, 5) . In these cohortstudiesalcoholintake waso nlya ssesseda tb aseline and variationso fa lcoholi ntake during follow-up mayhaveresultedinmisclassification of alcohollevelsand spurious estimates. In aFrench case-control study no effect of alcohol consumption wasfound (6) .Inthis study,the control group consisted of patients with influenzal or rhinopharyngealsymptomsinwhom alcohol consumption maydiffer from the base population of cases.Alcoholi sc onsumed regularly by twobillion people worldwide (7), whichmakes it impor-tant to elucidatethe relationshipbetween alcohol consumption and the risk of venous thrombosis.Inthe Multiple Environmental and Genetic Assessment of risk factorsfor venous thrombosis (MEGAstudy), alarge population-basedcase-controlstudy,we investigated alcohol useasarisk factor forvenous thrombosis. In addition we analyzed the association of alcohol consumption with fibrinogen, factor VII and vonWillebrand factor levels to verify if ap rotective effect could be explained by changes in these coagulation parameters.
Methods

Study design
Detailso ft he MEGA study have beenp ublished (8) .B etween March1 999 and September 2004, consecutive patients with a first deep venous thrombosis (DVT) of the legorapulmonary embolism (PE) were includedfrom sixanticoagulation clinics. All patients were between the age of 18 and 70.Patients with severe psychiatric problems or thoseunable to speakDutch were considered as ineligible.Partners of patients were asked to participate as control subjects. From January 2002 until September 2004, an additional control group wasrecruitedusing arandom digitd ialling method.P hone numbersw ere dialed at random within the geographical inclusionarea of the patients. During the phone callaspecificperson within ahousehold (e.g. youngest womanbetween 20 and 50)was askedtoparticipate.The random control subjects were frequencymatched to the patients with respect to age and sex. Onlycontrol subjects with no recent history of venous thrombosis were includeda nd the same exclusion criteriaapplied as for the patients.
Among the 6,055 eligible patients 5,051 participated (83%). Of the 5,051 participating patients, 3,656 had an eligible partner of whom 2,982 participated (82%). Of the 4,346 eligible random control subjects 3,000 participated (69%).
All participants gave written informed consent and thestudy wasa pprovedb yt he Medical Ethics Committee of the Leiden University Medical Center, Leiden, The Netherlands.
Data collection
Within afew weeks after diagnosis and registration at the anticoagulation clinicsp atients receivedal etterw ith information about the studyand were subsequently contacted by phone. If the patient waswilling to participate,aquestionnaire wassent.The control subjects received the questionnaires immediately after inclusionbyphone. The questionnaire wasreturned by 4,637 patients (77%), 2,821 partners( 77%) and 2,789 random control subjects (64%). The participants whodid not return aquestionnairew ere askedq uestions by phone. This shorti nterviewd id not include questionsregarding alcohol consumption.
The question referring to alcohol consumption includedten categorieso fa lcoholc onsumption: none, one glass or less per week, 2-6glassesper week, oneglass perday,2-4 glasses per day, 5-9 glasses per day, 10-19 glasses per day, 20-29 glasses per day, 30-39 glasses per dayand 40 or more glasses per day. Becauseo nly8 5i ndividuals filledi na na mounti nt he highest four categorieso fa lcoholc onsumption these categoriesw ere takent ogether in the analysis. Theq uestionnaire did not ask about kind of alcohol used. Participants whoreturned the questionnaire with missing data on alcohol consumption, body weight or height, smoking or pregnancywere excluded fromall analyses.The total excluded proportion wasthe same in patients (4.6%)and control subjects (4.7%). In the analysesonlypartner controls with aparticipating patient were includedleading to a totalof4,423 patients, 2,576 partner and 2,659 random control subjects for the present analyses.
Bloodcollection
At least three months after withdrawalofanticoagulation the patients and their partnersw ere askedtovisit the anticoagulation clinic after an overnightfastw hereab lood sample wasdrawn. Onlyincaseofcontinuous use for more than one year ab lood sample wast aken during anticoagulation therapy. From December 1999 onwards, we obtained self-administered buccal swabs by mail when participants were unable or unwilling to comefor ab lood draw.F rom June 2002 onwards,b lood draws were no longer performed in patients and their partners, and the study wasrestrictedtoDNA collection by buccal swabs sent by mail. Therandom controls were invitedfor ablood draw within afew weeks after the questionnairewas sent. Within this group buccal swabs were sentwhen someone refusedthe blood draw.
In the control subjects2 ,614 blood samples were obtained (50%). Fibrinogen, vonW illebrand factor and factor VII were successfully determinedi n2 ,612 samples. Fibrinogen activity wasmeasured on the STA-Ranalyzeraccording to methodsof Clauss (9) . The intra-assaycoefficient of variation (CV) was1.8, the inter-assayC Vw as 3.8. Factor VII activity (FVII) was measured with amechanical clot detection method on the STA-R analyzer followingt he instructions of the manufacturer (Diagnostica Stago, Asnieres, France).The intra-assayCVwas 3.4, the inter-assayC Vw as 4.0. Vo nW illebrand factor antigen( vWF) wasmeasured with the immuno-turbidimetric method,using the STAl iatest kit (rabbit anti-humanv WF antibodies),f ollowing the instructions of the manufacturer.F or vWF the intra-and inter-assayCVwere 3.6and 2.6.
Statisticalanalysis
Oddsratios (OR) were calculated as estimates of the relative risk with 95%confidenceintervals (CI95)according to the method of Woolf.Using amultiplelogistic regression modelORs were adjusted for age( continuous), sex( categorical),b ody mass index (BMI=kg/m 2 )( continuous), pregnancy( categorical) ands moking (categorical). Adjustment fora ge (10 categories)a nd body mass index (8 categories)ascategorical variables resulted in approximately the same riske stimates. Additionala djustmentf or diseasehistory, including malignancies,did notchange the risk estimates.Inthe analyses with the random control subjects an unmatchedanalysisincluding 4,423 patients and2,659 random control subjects wasperformed. In the analyses with partners as the control group (2,576 pairs),w ep erformedamatched analysis which adjusts forsimilar life-style factors between patients and their partners (10) . Because the results of the matched and the unmatched analyses showed consistentlyprotective relative risksin all analyses,w ecalculated pooledriskestimateswith amethod thatcombinesthe matchedand unmatchedanalyses (11) . When analyzing the risk in men and women separately it wasnot possibletoperformamatched analysis with the partnercontrols, there-fore riske stimatesw erec alculated with an unmatched analysis with all patients and the random control subjects.
AC hi 2 -test wasu sedt oc omparea lcoholc onsumption betweenpatients with DVTofthe legwith thoseinpatients with PE. SAS 9.1 (SAS institute Inc, Cary,NC, USA) wasusedfor all statisticalanalyses.
Results
In the currentanalysis 4,423 patients with afirst venous thrombosis and 5,235 control subjects were included. Mean age of the patients was48.5 years (5 th -95 th percentiles, 25.8-67.7) and the control subjects were on average46.8 years (5 th -95 th percentiles, 25.4-66.4). In the patient and in the control group 54% were women( n patient =2400, n control =2816). In the patient group 57% (n=2528) wasd iagnosedw ith DVTo ft he leg, nearlyat hird (n=1340) with PE and 13% (n=555) with the combined diagnosis of DVTand PE. Figure 1s hows the relationshipb etween alcohol consumption and the risk of venous thrombosis.Moderate alcohol consumption wasassociatedwith adecreased risk of venous thrombosis, with twotofour glasses per dayresulting in the strongest effect on the risk of venous thrombosis (OR 2-4/day 0.67, CI95 0.58-0.77) comparedt oa bstainers. Even drinking more than four glasses per daya ppearedt ob es till somewhat protective (OR 5-9/day 0.82, CI95 0.65-1.04, OR ≥10/day 0.71, CI95 0.45-1.12). Moderate alcohol consumption wasassociatedwith asomewhat moredecreased risk forwomen (OR 2-4/day 0.66, CI95 0.53-0.84) than men (OR 2-4/day 0.82, CI95 0.63-1.07).
The associations of alcohol consumption with the risk of DVTand PE separatelyare presented in Figure 2 . The protective effect of alcohol consumption appeared to be morepronounced for the diagnosis of PE (OR 2-4/day 0.56, CI95 0.46-0.70) than for DVT(OR 2-4/day 0.74, CI95 0.63-0.88).Drinking twoglassesper week or morec learlyp rotected morea gainst PE thana gainst DVT(p=0.02).
In Figure 3mean fibrinogen, factor VII and vonWillebrand factor levels are presented ford ifferent categories of alcohol consumption in control subjects. Alcohol consumption categorieswhich were associated with the most pronounced reduction in venous thromboticrisk were alsoassociatedwith reduced levels of fibrinogen. Factor VII levels and vonWillebrand factor levels were alsol ower in drinkers thann on-drinkers, butt here were no consistent patternso verthe categoriesofalcoholconsumption.
Discussion
In this largec ase-controls tudy moderate alcoholc onsumption wasassociatedwith adecreased risk of venous thrombosis.This potential beneficial effect of moderate alcoholconsumption appearedtobemore pronounced in womenthan men and for PE than for DVTofthe leg.
Ve ry little is known about the mechanisms by whichalcohol mayexert antithrombotic effects. Some studieshaveshown that moderate alcohol consumption is associated with amore favorable coagulation profile,indicated by lowerlevelsoffibrinogen, factor VII and vonWillebrand factor (12, 13) . In accordance with these studiesw efound reducedlevelsoffibrinogen, factor VII and vonW illebrand factor in moderate alcohold rinkers. Reduced levels were most striking for fibrinogen, where levels were even decreased up to high levels of alcohol consumption (5-9 glassesper day).
Thed ifference between mena nd womeni nt he alcohol-related risk of venous thrombosis maybeexplained by the differentialeffectsofwine and beer (14) ,the latter of whichisconsumed more by menthan women. Unfortunately,inour study we had no information about the kind of alcoholic drinks the partici- pants consumed. Aquestion about type of alcoholic drinks could have provided important additional information. Arecent study however, showedthat wine, beerand spirits were to the same extent protectivefor myocardialinfarction, suggesting that type of alcohol drink did not influencethe effect (15) .
It wass triking thatt he protective effect of drinkingt wo or more glasses of alcohol per week washigherfor PE than for DVT of the leg. We do not have an explanation for these findings.
Al imitation of our studyi st hat alcohol consumption was self-reported.A lthough it is possible thati ndividuals underreportalcoholconsumption, this is mainlyaproblemwhen there is adifference between patients and control subjectsinreporting behavior.I fp atients and controls both hadu nderreported,t he protective effect we observedw as underestimated. If patients underreportedm ore than controls, the true effect would have beenlesspronounced. Theproportion of individualswho failed to report their alcohol consumption wast he same in patients (0.71%)a nd controls (0.66%), whichs uggests that the two groups behavedsimilarlyinanswering this question.
In conclusion,i nt his large population-based case-control study alcohol consumption is associated with adecreased risk of venous thrombosis,with twotofour glasses per dayresulting in 
